Codexis (CDXS) Other Non-Current Assets (2010 - 2026)
Codexis (CDXS) posted quarterly Other Non-Current Assets of $425000.0 for Q1 2026, down 56.05% year-over-year from $967000.0 in Q1 2025, and down 11.09% quarter-over-quarter from $478000.0 in Q4 2025.
Codexis (CDXS) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Codexis' Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $425000.0 for Q1 2026.
- In Q1 2026, Other Non-Current Assets fell 56.05% year-over-year to $425000.0; the TTM figure through Mar 2026 stood at $425000.0 (down 56.05% YoY), while the FY2025 annual figure was $478000.0, down 54.99% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $425000.0, down from $478000.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $1.8 million in Q2 2024, with the low at $208000.0 in Q3 2022.
- The 5-year median for Other Non-Current Assets is $967000.0 (2025), against an average of $940705.9.
- The sharpest annual moves came in 2022 and 2023: Other Non-Current Assets plunged 86.31% in 2022, then soared 410.58% in 2023.
- Codexis' Other Non-Current Assets stood at $521000.0 in 2022, then jumped by 103.84% to $1.1 million in 2023, then changed by 0.0% to $1.1 million in 2024, then plunged by 54.99% to $478000.0 in 2025, then dropped by 11.09% to $425000.0 in 2026.
- Business Quant data shows CDXS's Other Non-Current Assets at $425000.0 in Q1 2026, $478000.0 in Q4 2025, and $485000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 618.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 109.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 65.13 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 202.31 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 104.44 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 62.96 Mn |
| 10 | Codexis | 152.06 Mn | 97.14 Mn | 11.40 Mn | 1.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.61 Mn |
| Mar 31, 2026 | 425,000.00 |
| Dec 31, 2025 | 478,000.00 |
| Sep 30, 2025 | 485,000.00 |
| Jun 30, 2025 | 950,000.00 |
| Mar 31, 2025 | 967,000.00 |
| Dec 31, 2024 | 1.06 Mn |
| Sep 30, 2024 | 514,000.00 |
| Jun 30, 2024 | 1.84 Mn |
| Mar 31, 2024 | 1.35 Mn |
| Dec 31, 2023 | 1.06 Mn |
| Sep 30, 2023 | 1.06 Mn |
| Jun 30, 2023 | 498,000.00 |
| Mar 31, 2023 | 1.53 Mn |
| Dec 31, 2022 | 521,000.00 |
| Sep 30, 2022 | 208,000.00 |
| Jun 30, 2022 | 1.52 Mn |
| Mar 31, 2022 | 1.52 Mn |
| Dec 31, 2021 | 579,000.00 |
| Sep 30, 2021 | 1.52 Mn |